Conestoga Capital Advisors’s AbbVie ABBV Stock Holding History

Conestoga Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,935	Closed	-$850K	–	142
2020 Q4	$850K	Hold	7,935	–	–	0.01%	104
2020 Q3	$695K	Hold	7,935	–	–	0.01%	105
2020 Q2	$779K	Hold	7,935	–	–	0.02%	104
2020 Q1	$605K	Hold	7,935	–	–	0.02%	90
2019 Q4	$703K	Hold	7,935	–	–	0.02%	93
2019 Q3	$601K	Hold	7,935	–	–	0.02%	88
2019 Q2	$577K	Hold	7,935	–	–	0.01%	89
2019 Q1	$639K	Hold	7,935	–	–	0.02%	87
2018 Q4	$732K	Hold	7,935	–	–	0.02%	85
2018 Q3	$750K	Hold	7,935	–	–	0.02%	85
2018 Q2	$735K	Hold	7,935	–	–	0.02%	82
2018 Q1	$751K	Hold	7,935	–	–	0.03%	81
2017 Q4	$767K	Hold	7,935	–	–	0.03%	79
2017 Q3	$705K	Hold	7,935	–	–	0.03%	76
2017 Q2	$575K	Hold	7,935	–	–	0.03%	78
2017 Q1	$517K	Hold	7,935	–	–	0.03%	78
2016 Q4	$497K	Hold	7,935	–	–	0.03%	73
2016 Q3	$500K	Hold	7,935	–	–	0.03%	73
2016 Q2	$491K	Sell	7,935 -1,005	-11%	-$61.2K	0.04%	72
2016 Q1	$511K	Hold	8,940	–	–	0.03%	64
2015 Q4	$530K	Hold	8,940	–	–	0.04%	65
2015 Q3	$486K	Hold	8,940	–	–	0.04%	64
2015 Q2	$601K	Hold	8,940	–	–	0.04%	62
2015 Q1	$523K	Sell	8,940 -1,500	-14%	-$90.6K	0.04%	69
2014 Q4	$683K	Hold	10,440	–	–	0.05%	59
2014 Q3	$603K	Hold	10,440	–	–	0.04%	54
2014 Q2	$589K	Hold	10,440	–	–	0.04%	57
2014 Q1	$537K	Sell	10,440 -1,110	-10%	-$56.1K	0.03%	74
2013 Q4	$610K	Hold	11,550	–	–	0.04%	74
2013 Q3	$517K	Hold	11,550	–	–	0.04%	66
2013 Q2	$477K	Buy	+11,550	New	+$505K	0.05%	64

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Conestoga Capital Advisors's ABBV Position: Q1 2021 in Review

Conestoga Capital Advisors sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 7,935 shares — an estimated $850K sold.

Conestoga Capital Advisors first reported a position in ABBV in Q2 2013 and held it in 31 quarters. The position peaked at $850K in Q4 2020. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

Conestoga Capital Advisors reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
Conestoga Capital Advisors sold 7,935 AbbVie shares in Q1 2021, an estimated $850K.
Conestoga Capital Advisors first reported a position in AbbVie in Q2 2013 and held it in 31 quarters.
Conestoga Capital Advisors's AbbVie position peaked at $850K in Q4 2020.
2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Conestoga Capital Advisors's 13F filing for Q1 2021, filed 23 Apr 2021.